Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB) World Health Organization
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
WHO Meeting on Live Attenuated Influenza Vaccine Effectiveness 20-21 September, 2016 Salle B, WHO Headquarters
List of Participants
Participants
Edward A. Belongia, Director, Center for Clinical Epidemiology and Population Health Marshfield Clinic Research Foundation, Marshfield, United States of America
Tatiana Bousse, Virology, Surveillance and Diagnosis Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, United States of America
Helen Bright, Virology Flu MSAT Team, Medimmune, Liverpool, United Kingdom of Great Britain & Northern Ireland
Nancy J. Cox, Atlanta, United States of America
Rajeev M. Dhere, Senior Director, Vaccine Production, Vaccine Department, Serum Institute of India Ltd, Pune, India
Ruben Donis, Deputy Director, Influenza and Emerging Diseases Division, BARDA, US Department of Health and Human Services, Washington, United States of America
Matthew Downham, Associate Director, Flu Manufacturing Sciences & Technology, Medimmune, Liverpool, United Kingdom of Great Britain & Northern Ireland
Filip Dubovsky, Vice President, Clinical Development, Therapeutic Area Head, Vaccines, MedImmune, Gaithersburg, United States of America
Stacey Efstathiou, Head of Viral Vaccines, Virology, National Institute for Biological Standards & Control, Potters Bar, United Kingdom of Great Britain & Northern Ireland
Alicia Fry, Lead, Influenza Prevention and Control team, Epidemiology and Prevention Branch, Centers for Disease Control and Prevention, Atlanta, United States of America
Finnian Hanrahan, Policy/Scientific Officer, Fighting Diseases and Advancing Public Health, European Commission, Brussels, Belgium
Kari Johansen, Expert Influenza and other Vaccine Preventable Diseases, Surveillance and Response Support Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden
Ruth Karron, Professor, International Health, Director, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
David C. Kaslow, Vice President, Product Development, PATH, Seattle, United States of America
Wendy A. Keitel, Professor of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, United States of America
Esther Kissling, Epidemiologist, EpiConcept, Paris, France
Paul-Henri Lambert, Director ADVAC, Center for Vaccinology, Centre Médical Universitaire, Genève, Switzerland
Geert Leroux-Roels, Ghent University and Ghent University Hospital, Ghent, Belgium
Raburn Mallory, Director, Clinical Development, Infectious Disease & Vaccines, MedImmune Inc, Gaithersburg, United States of America
Punam Mangtani, Associate Professor, Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom of Great Britain & Northern Ireland
Jim McMenamin, Health Protection Scotland, National Services Scotland, Glasgow, United Kingdom of Great Britain & Northern Ireland
Arnold S. Monto, Professor, Dept of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, United States of America
Hanna Nohynek, Chief Physician, Team Leader, Health Protection, KTL National Public Health Institute, Helsinki, Finland
Richard Pebody, Acting Head, Respiratory Diseases Department, Public Health England, London, United Kingdom of Great Britain & Northern Ireland
Pasi Penttinen, Head, Disease Programme Influenza and other Respiratory Viruses, European Center for Disease Prevention and Control, Solna, Sweden
Julie Phillips, Chief Executive Officer, BioDiem Ltd, South Melbourne, Australia
Andrew J. Pollard, Professor of Paediatric Infection and Immunity, Director of the Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom of Great Britain & Northern Ireland
Kittisak Poopipatpol, Influenza Vaccine Plant Manager, The Government Pharmaceutical Organization, Bangkok, Thailand
Cornelius Remschmidt, Research Associate/Senior Epidemiologist, Immunization Unit, Robert Koch Institut, Berlin, Germany
Gustaaf (Guus) Rimmelzwaan, Viroscience, Erasmus Medical Center, Rotterdam, Netherlands
Larisa Rudenko, Head, Department of Virology, Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", St. Petersburg, Russian Federation
Danuta M. Skowronski, Epidemiology Lead, Influenza & Emerging Respiratory Pathogens, BC Centre for Disease Control, Vancouver, Canada
David Spiro, Chief, Respiratory Diseases Branch, National Institute of Allergy and Infectious Diseases, Rockville, United States of America
Kanta Subbarao, Senior Investigator, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, United States of America
Somchaiya Surichan, Head of Viral Vaccine Unit, Research and Development Institute (RDI), The Government Pharmaceutical Organization, Bangkok, Thailand
Sit Thirapakpoomanunt, Director of the Viral Division, The Government Pharmaceutical Organization, Bangkok, Thailand
Paul Thomas, St Jude's Children's Research Hospital, Memphis, United States of America
John (Chris) Victor, Advisor for Epidemiologic Science and Clinical Trials, Vaccine and Delivery Global Program, PATH, Seattle, United States of America
Niteen Wairagkar, Senior Program Officer, Pneumonia, Global Health, Bill and Melinda Gates Foundation, Seattle, United States of America
John Martin Watson, Deputy Chief Medical Officer, Department of Health, London, United Kingdom of Great Britain & Northern Ireland
Ponthip Wirachwong, Director of Biological Research Group, Research and Development Institute, The Government Pharmaceutical Organization, Bangkok, Thailand
Leena Ravindra Yeolekar, Scientist, Pandemic Influenza Vaccine, Serum Institute of India Limited, Pune, India
Observers
Sarah Browne, Medical Officer, Office of Vaccine Research and Review, FDA Center for Biologics Evaluation and Research (CBER), Silver Spring, United States of America
Manuela Mura, Scientific Officer, Anti-Infectives and Vaccines Office, Scientific and Regulatory Management Department, European Medicines Agency, London, United Kingdom of Great Britain & Northern Ireland
Secretariat
Martin Friede, Coordinator, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Gerhard (Gary) Grohmann, Technical Officer, Influenza, Hepatitis and PIP Framework, World Health Organization, Geneva, Switzerland
Joachim Hombach, Senior Adviser, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Pernille Jorgensen, Technical Officer, Division of Communicable Diseases and Health Security, World Health Organization Regional Office for Europe, Copenhagen, Denmark
Philipp Lambach, Medical Officer, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Justin Ortiz, Medical Officer, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
David Wood, Coordinator, Technologies Standards and Norms, World Health Organization, Geneva, Switzerland
Wenqing Zhang, Scientist, Global Influenza Programme/Virus Monitoring, Assessment and Vaccine Support, World Health Organization, Geneva, Switzerland